Ongoing Clinical Trials

This page is often updated with new and upcoming trials for a variety of therapeutic areas. Clinical trials are conducted to collect data regarding the safety and efficacy of new drug and device development. There are several steps and stages of approval in the clinical trials process before a drug or device can be sold in the consumer market, if ever. Learn about our clinical trials & additional resources

Squamous Cell Carcinoma Study A Phase 1 Study of Pre-Operative Cemiplimab (REGN2810), Administered Intralesionally, for Patients With Recurrent Cutaneous Squamous Cell Carcinoma
Request Info
Skin Cancer Gene Expression Study Prospective Validation of a Gene Expression Assay to Predict the Risk of Recurrence Disease in Cutaneous Squamous Cell Carcinoma
Request Info
Immunology of Skin Cancer Study Prospective, Non-Interventional Natural History Study of Tumor Tissue, Molecular and Cellular Tumor and Immune Biomarkers in High Risk Resectable Cutaneous Squamous Cell Carcinoma (CSCC) and Basal Cell Carcinoma (BCC)
Request Info
Non-Invasive Rapid Imaging of Skin Cancer Study Non-linear microscopy for the rapid processing of Mohs surgery specimens to reduce processing time and improve accuracy
Request Info
Under Eye Hollow Study A Randomized, Evaluator-blinded, Parallel Group, No-treatment Controlled, Multi-center Study to Evaluate the Safety and Effectiveness of Restylane-L® for Correction of Infraorbital Hollows Closed to Enrollment
Crow’s Feet Study A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Lateral Canthal Lines Closed to Enrollment

Frequently Asked Questions

Study participants will receive study medication and study-related exams at no cost. Compensation for time and travel may be available.